The macrophage migration inhibitory factor protein superfamily in obesity and wound repair

다국어 초록 (Multilingual Abstract)

The rising number of obese individuals has become a major burden to the healthcare systems worldwide. Obesity includes not only the increase of adipose tissue mass but importantly also the altered cellular functions that collectively lead to a chronic state of adipose tissue inflammation, insulin resistance and impaired wound healing. Adipose tissue undergoing chronic inflammation shows altered cytokine expression and an accumulation of adipose tissue macrophages (ATM). The macrophage migration inhibitory factor (MIF) superfamily consists of MIF and the recently identified homolog D-dopachrome tautomerase (D-DT or MIF-2). MIF and D-DT, which both bind to the CD74/CD44 receptor complex, are differentially expressed in adipose tissue and have distinct roles in adipogenesis. MIF positively correlates with obesity as well as insulin resistance and contributes to adipose tissue inflammation by modulating ATM functions. D-DT, however, is negatively correlated with obesity and reverses glucose intolerance. In this review, their respective roles in adipose tissue homeostasis, adipose tissue inflammation, insulin resistance and impaired wound healing will be reviewed.

참고문헌 (Reference)

1 Koska J, "mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action" 33 : 842-850, 2009

2 Diegelmann RF, "Wound healing: an overview of acute, fibrotic and delayed healing" 9 : 283-289, 2004

3 Lee J, "Ultraviolet A regulates adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via up-regulation of Kruppel-like factor 2" 285 : 32647-32656, 2010

4 Sonesson B, "UVB-induced inflammation gives increased d-dopachrome tautomerase activity in blister fluid which correlates with macrophage migration inhibitory factor" 12 : 278-282, 2003

5 Velickovic N, "Tissue-specific regulation of inflammation by macrophage migration inhibitory factor and glucocorticoids in fructose-fed Wistar rats" 110 : 456-465, 2013

6 Cereijo R, "Thermogenic brown and beige/brite adipogenesis in humans" 18 : 1-9, 2014

7 Nikolic I, "The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice" 714 : 498-506, 2013

8 Sanchez-Zamora YI, "The role of MIF in type 1 and type 2 diabetes mellitus" 2014 : 804519-, 2014

9 Atsumi T, "The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation" 179 : 5399-5406, 2007

10 Fingerle-Rowson G, "The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting" 100 : 9354-9359, 2003

11 Calandra T, "The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor" 179 : 1895-1902, 1994

12 Alvehus M, "The human visceral fat depot has a unique inflammatory profile" 18 : 879-883, 2010

13 Abdel-Moneim RI, "The hazards of surgery in the obese" 70 : 101-103, 1985

14 Mantovani A, "The chemokine system in diverse forms of macrophage activation and polarization" 25 : 677-686, 2004

15 Iwata T, "The action of D-dopachrome tautomerase as an adipokine in adipocyte lipid metabolism" 7 : e33402-, 2012

16 Merk M, "The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)" 108 : E577-E585, 2011

17 Niinikoski J, "Respiratory gas tensions and collagen in infected wounds" 175 : 588-593, 1972

18 Skurk T, "Relationship between adipocyte size and adipokine expression and secretion" 92 : 1023-1033, 2007

19 Sakaue S, "Regulation of macrophage migration inhibitory factor(MIF)expression by glucose and insulin in adipocytes in vitro" 5 : 361-371, 1999

20 Heinrichs D, "Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis" 28 : 5136-5147, 2014

21 Sakaue S, "Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity" 30 : 238-242, 2006

22 Skurk T, "Production and release of macrophage migration inhibitory factor from human adipocytes" 146 : 1006-1011, 2005

23 Flegal KM, "Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010" 307 : 491-497, 2012

24 Arita Y, "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity" 257 : 79-83, 1999

25 Nishihira J, "Overview of macrophage migration inhibitory factor(MIF)as a potential biomarker relevant to adiposity" 2 : 186-191, 2012

26 Church TS, "Obesity, macrophage migration inhibitory factor, and weight loss" 29 : 675-681, 2005

27 Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue" 112 : 1796-1808, 2003

28 Lumeng CN, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization" 117 : 175-184, 2007

29 Pierpont YN, "Obesity and surgical wound healing: a current review" 2014 : 638936-, 2014

30 Fingerle-Rowson GR, "Neuroendocrine properties of macrophage migration inhibitory factor(MIF)" 79 : 368-375, 2001

31 Fain JN, "Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes" 55 : 1113-1121, 2006

32 Bloom BR, "Mechanism of a reaction in vitro associated with delayed-type hypersensitivity" 153 : 80-82, 1996

33 Stosic-Grujicic S, "Macrophage migration inhibitory factor(MIF)is necessary for progression of autoimmune diabetes mellitus" 215 : 665-675, 2008

34 Grieb G, "Macrophage migration inhibitory factor(MIF) : a promising biomarker" 23 : 257-264, 2010

35 Hsieh CY, "Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-gamma-mediated skin inflammation" 193 : 3693-3703, 2014

36 Bozza FA, "Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis" 22 : 309-313, 2004

37 Sanchez-Zamora Y, "Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus" 24 : 2583-2590, 2010

38 Saksida T, "Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis" 90 : 688-698, 2012

39 Stojanovic I, "Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro" 169 : 156-163, 2012

40 Serre-Beinier V, "Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice" 206 : 297-306, 2010

41 Finucane OM, "Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis" 9 : e113369-, 2014

42 Lolis E, "Macrophage migration inhibitory factor" 7 : 153-164, 2003

43 Bernhagen J, "MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment" 13 : 587-596, 2007

44 Verschuren L, "MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease" 105 : 99-107, 2009

45 Conine SJ, "MIF deficiency does not alter glucose homeostasis or adipose tissue inflammatory cell infiltrates during diet-induced obesity" 22 : 418-425, 2014

46 Calandra T, "MIF as a glucocorticoid-induced modulator of cytokine production" 377 : 68-71, 1995

47 Gilliver SC, "MIF : a key player in cutaneous biology and wound healing" 20 : 1-6, 2011

48 Haase J, "Local proliferation of macrophages in adipose tissue during obesity-induced inflammation" 57 : 562-571, 2014

49 Amano SU, "Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation" 19 : 162-171, 2014

50 Tam CS, "Little evidence of systemic and adipose tissue inflammation in overweight individuals(dagger)" 3 : 58-, 2012

51 Nicoletti G, "Lipofilling for functional reconstruction of the sole of the foot" 24 : 21-27, 2014

52 Ikeda D, "Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells" 149 : 6037-6042, 2008

53 Schmidt BA, "Intradermal adipocytes mediate fibroblast recruitment during skin wound healing" 140 : 1517-1527, 2013

54 Waeber G, "Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor" 94 : 4782-4787, 1997

55 Dandona P, "Increased plasma concentration of macrophage migration inhibitory factor(MIF)and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin" 89 : 5043-5047, 2004

56 Kos K, "In humans the adiponectin receptor R2 is expressed predominantly in adipose tissue and linked to the adipose tissue expression of MMIF-1" 12 : 360-363, 2010

57 Delamaire M, "Impaired leucocyte functions in diabetic patients" 14 : 29-34, 1997

58 Rosner K, "Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers" 103 : 293-299, 1995

59 Hirokawa J, "Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha" 235 : 94-98, 1997

60 Ng M, "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013" 384 : 766-781, 2014

61 Harford KA, "Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue" 70 : 408-417, 2011

62 Pence BD, "Exercise, obesity, and cutaneous wound healing:evidence from rodent and human studies" 3 : 71-79, 2014

63 Landgraf K, "Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children" 2014

64 Karastergiou K, "Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells" 30 : 1340-1346, 2010

65 Hermanowski-Vosatka A, "Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration" 38 : 12841-12849, 1999

66 Weyer C, "Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance" 43 : 1498-1506, 2000

67 Kim H, "Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome" 43 : 642-645, 2011

68 Sugihara H, "Effects of fat cells on keratinocytes and fibroblasts in a reconstructed rat skin model using collagen gel matrix culture" 144 : 244-253, 2001

69 Herder C, "Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002" 51 : 276-284, 2008

70 Sindrilaru A, "Disclosure of the culprits : macrophages-versatile regulators of wound healing" 2 : 357-368, 2013

71 Bertile F, "Differences in mRNA expression of adipocyte-derived factors in response to fasting, refeeding and leptin" 1683 : 101-109, 2004

72 Merk M, "D-dopachrome tautomerase(D-DT or MIF-2) : doubling the MIF cytokine family" 59 : 10-17, 2012

73 Ishimoto K, "D-dopachrome tautomerase promotes IL-6 expression and inhibits adipogenesis in preadipocytes" 60 : 772-777, 2012

74 Sugimoto H, "Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54A resolution" 38 : 3268-3279, 1999

75 Yaddanapudi K, "Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor" 190 : 2984-2993, 2013

76 Fain JN, "Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans" 145 : 2273-2282, 2004

77 Ghanim H, "Circulating mononuclear cells in the obese are in a proinflammatory state" 110 : 1564-1571, 2004

78 Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance" 112 : 1821-1830, 2003

79 Sun X, "Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk" 19 : 392-399, 2008

80 Aoki S, "Bone marrow stromal cells, preadipocytes, and dermal fibroblasts promote epidermal regeneration in their distinctive fashions" 15 : 4647-4657, 2004

81 Hyun S, "Body mass index and pressure ulcers: improved predictability of pressure ulcers in intensive care patients" 23 : 494-500, 2014

82 Sindrilaru A, "An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice" 121 : 985-997, 2011

83 Toyserkani NM, "Adipose-derived stem cells: new treatment for wound healing?" 2014

84 Lanthier N, "Adipose tissues as endocrine target organs" 28 : 545-558, 2014

85 Morris DL, "Adipose tissue macrophages : phenotypic plasticity and diversity in lean and obese states" 14 : 341-346, 2011

86 Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha : direct role in obesity-linked insulin resistance" 259 : 87-91, 1993

87 Campbell CA, "Adipocytes constitutively release factors that accelerate keratinocyte proliferation in vitro" 64 : 327-332, 2010

88 Trayhurn P, "Adipocyte biology" 8 (8): 41-44, 2007

89 Kevill KA, "A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome" 180 : 601-608, 2008

90 Hill AA, "A decade of progress in adipose tissue macrophage biology" 262 : 134-152, 2014